Lab Exit, Sale & Transition Planning

Laboratory Exit Planning for Lab Closures, Sales, and Facility Transitions

pForm helps plan and execute lab exits where equipment, facility contents, decontamination status, buyer interest, landlord timelines, removal logistics, and sale strategy all need to be coordinated — not handled as separate, disconnected problems.

Whole-lab and equipment sale strategy

Asset inventory and valuation

Inspection and buyer-readiness documentation

Decontamination and closeout coordination

Confidential buyer marketing

Removal and logistics coordination

When it comes up

When Labs Need an Exit Plan

  • Company shutdown
  • Funding loss
  • Relocation
  • Consolidation
  • M&A cleanup
  • Lease expiration
  • Clinical lab closure
  • Biotech or pharma downsizing
  • University / research lab transition
  • Receivership or distressed asset situation

Why one plan

One Plan for Assets, Sale Strategy, Closeout, and Removal

Lab exits fail when equipment sale, decontamination, waste removal, logistics, landlord deadlines, and buyer communication are each handled separately with no central plan. A missed decon step blocks removal. A removal scheduled before a sale closes loses a buyer. A landlord deadline nobody tracked against the sale timeline turns into holdover costs. pForm's lab exit planning brings all of it under one coordinated plan, sequenced against your actual deadline.

Sale strategy

Sale Path Options

There is no single best path for every lab exit. The right combination depends on the asset mix, your timeline, and what you're optimizing for.

PathBest forAdvantagesTradeoffs
Whole-lab saleA buyer wants an existing operational footprint, in place.Single transaction; turnkey appeal can command a premium from the right buyer.Smaller buyer pool; pricing reflects a bulk-package view.
Equipment package saleBundled equipment without the full facility.Faster than itemized resale; appeals to buyers furnishing a new space.Typically below peak per-instrument value.
Targeted resaleHigh-value individual instruments with a known buyer audience.Can realize the strongest price for in-demand equipment.Slower; requires per-instrument buyer outreach.
AuctionMixed inventory with several in-demand items.Buyer competition drives price discovery.Variable outcomes; requires a defined listing window.
Consignment through resale channelsQuality equipment where time allows for individual sale.Higher realized value than bulk on most categories, including via mLab Supply.Recovery happens over weeks-to-months; storage logistics required.
Direct purchaseA fast, predictable exit where certainty matters more than peak price.Single payment, single removal window, minimal coordination.Bulk price; below auction-best on in-demand instruments.
Liquidation / removal-first strategyLease deadlines that don't allow time for a sale process to fully play out.Clears the site on schedule; protects against holdover costs.Lower per-unit recovery in exchange for speed and certainty.

Valuation

Asset Inventory and Valuation

A realistic recovery estimate starts with a complete inventory and weighs several reference points against each other:

Equipment list creation

Manufacturer, model, and quantity for every recoverable asset.

Photos and serial numbers

Documentation that lets buyers evaluate equipment without an in-person visit.

Condition notes

Working, untested, or parts-only status recorded for each item.

Service records

Available maintenance and calibration history collected where it exists.

Accessories / software / computer notes

What's included, what's missing, and any software or control-PC dependencies.

Fair market value

What comparable equipment realistically sells for in the current secondary market.

Orderly liquidation value

A more conservative estimate reflecting a structured sale within a defined timeframe.

Auction value

What competitive bidding tends to produce for in-demand, individually listed instruments.

Replacement-cost context

New-equipment pricing, used only as context — not as a basis for sale price.

Removal / logistics cost impact

Freight, rigging, and decontamination costs that affect net recovery.

Inspection

Lab Inspection and Buyer-Readiness Review

  • Asset verification
  • Visible condition documentation
  • Decon status documentation
  • Equipment removability
  • Missing parts or accessories
  • Buyer-facing asset schedules
  • Service record collection
  • Inspection-style documentation for sale planning

pForm can document and organize laboratory assets for sale and buyer due diligence. This is an asset documentation review — we do not perform regulatory compliance certification, environmental clearance, biosafety certification, engineering inspection, or contamination clearance unless performed by qualified professionals.

Closeout

Decontamination and Facility Closeout Coordination

  • Decontamination planning
  • Hazardous waste / vendor coordination
  • Biological material closeout
  • Chemical inventory and waste considerations
  • Biosafety cabinet / fume hood decon coordination
  • Landlord closeout requirements
  • Final removal sequencing

pForm may coordinate with qualified decontamination, environmental, hazardous waste, biosafety, rigging, and facility vendors where required. We do not directly perform regulated decontamination, hazardous waste disposal, environmental remediation, or regulatory clearance unless separately authorized, licensed, insured, and contracted to do so. See our laboratory decontamination coordination page for the dedicated process, or our compliance & risk approach for more detail.

Important boundaries

Lease, Business, Legal, and Regulatory Boundaries

pForm focuses on lab assets, sale strategy, documentation, buyer marketing, removal planning, and recovery coordination. We are not a real estate broker, business broker, attorney, regulatory consultant, or clinical lab compliance advisor.

Lease assignment or sublease, business sale, ownership transfer, real estate, CLIA/COLA/CAP or other accreditation, Medicare or payer enrollment, permits, legal or regulatory matters, and facility compliance matters are handled separately by the appropriate professionals and approved parties.

Any seller-reported business, lease, licensing, revenue, accreditation, or regulatory information is subject to independent buyer due diligence. Transferability of any lease, license, accreditation, payer enrollment, permit, business operation, or ownership interest is not guaranteed.

Who we work with

Lab Types Supported

  • Biotech R&D
  • Pharma
  • Clinical diagnostic
  • Molecular
  • Analytical testing
  • University / research
  • Industrial / QC
  • Cannabis / hemp testing

Process

pForm Lab Exit Process

Every exit plan runs through the same nine steps. The depth of each one scales with the size and complexity of the facility.

  1. 01

    Initial exit review

    A conversation to understand why you're exiting, your timeline, and the scope of the facility and equipment.

  2. 02

    Facility timeline and stakeholder review

    Mapping lease, landlord, board, or creditor deadlines against the realistic sale and closeout timeline.

  3. 03

    Asset inventory and document collection

    Equipment list, photos, manufacturer/model data, and any available service records.

  4. 04

    Valuation and sale-channel strategy

    A recovery estimate and recommendation across whole-lab, equipment package, targeted resale, auction, consignment, or direct purchase.

  5. 05

    Inspection / buyer-readiness review

    Condition documentation and buyer-facing asset schedules built from the inventory.

  6. 06

    Decon and closeout planning where needed

    Sequencing decontamination, hazardous-material closeout, and removal logistics against the facility deadline.

  7. 07

    Buyer marketing, auction, resale, or liquidation execution

    Running the selected sale-channel strategy, including confidential buyer outreach where appropriate.

  8. 08

    Removal, pickup, shipping, or transition coordination

    Coordinated logistics through to a documented closeout, aligned with your lease or transition deadline.

  9. 09

    Final reporting and recovery summary

    A closeout report covering disposition records and the realized recovery breakdown.

Why pForm

Why pForm

Lab equipment resale knowledge

We understand which instrument categories hold value and how buyers evaluate them.

Asset recovery experience

Structured recovery programs across laboratory, biotech, pharma, and industrial equipment.

mLab Supply resale channel

Recovered equipment can be evaluated and listed through our partner marketplace for pre-owned lab instrumentation.

Whole-lab sale strategy

We evaluate whether a complete package sale fits, alongside individual equipment paths.

Auction / liquidation fallback

A built-in fallback if a whole-lab or targeted sale doesn't close in your timeline.

Inspection and documentation process

Buyer-ready asset schedules built from a consistent inspection and documentation process.

Decon / removal coordination awareness

We understand the decontamination and removal sequencing that affects timing and access.

Confidential seller process

NDA-gated buyer access and de-identified listing packages by default.

Support across stakeholders

We work with owners, operators, finance teams, landlords, and receivers — not just one type of seller.

FAQ

Laboratory exit planning — frequently asked questions

What is laboratory exit planning?+

Laboratory exit planning is the coordinated process of closing, selling, relocating, or transitioning a lab facility — bringing equipment sale strategy, asset valuation, decontamination and closeout planning, buyer marketing, and removal logistics under one plan instead of handling each piece separately and reactively.

When should a lab start planning its closure or sale?+

As early as possible — ideally as soon as a shutdown, relocation, consolidation, or sale decision is being considered, even before it's announced. Starting early gives you more sale-channel options, more time for buyer marketing, and more room to sequence decontamination and removal against your actual deadline rather than a compressed one.

Can pForm help sell the entire lab?+

Yes. A whole-lab package sale is one of several paths we evaluate, alongside equipment package sale, targeted resale, auction, consignment, and direct purchase. See our whole-lab sale options for the dedicated process.

Is liquidation better than a whole-lab sale?+

Not universally. A whole-lab sale can realize a premium when a buyer wants a turnkey operational footprint. Liquidation — auction, consignment, or targeted resale of individual equipment — often realizes more for high-demand instruments specifically. Most exit plans run a whole-lab marketing effort in parallel with a liquidation fallback so the timeline isn't put at risk.

Can pForm inspect and document the equipment?+

Yes. We can document and organize laboratory assets for sale and buyer due diligence — condition, photos, major-equipment identification, missing accessories, and available service records. This is an asset documentation review, not a regulatory compliance certification, environmental clearance, biosafety certification, or engineering inspection.

Does lab equipment need to be decontaminated before sale or removal?+

Many lab assets — particularly those exposed to biological, chemical, or radiological materials — need decontamination before sale or removal, and buyers increasingly expect documentation of it. We help plan and coordinate decontamination through qualified vendors; we do not perform regulated decontamination ourselves.

Can pForm handle hazardous waste or biological materials?+

We coordinate with qualified hazardous waste, environmental, and biosafety vendors where needed and help sequence that work against your sale and removal timeline. We do not directly perform regulated hazardous waste disposal, environmental remediation, or biological material destruction — that work must be performed by separately authorized, licensed, and insured vendors.

Can pForm help with lease, business, or ownership transfer?+

No — those are separate matters. Lease assignment or sublease, business sale, ownership transfer, real estate, CLIA/COLA/CAP or other accreditation, Medicare or payer enrollment, and permits must be handled by the appropriate parties and qualified professionals. We focus on lab assets, sale strategy, documentation, buyer marketing, removal planning, and recovery coordination. Any business, lease, licensing, revenue, accreditation, or regulatory information referenced during a process is seller-reported and subject to independent buyer due diligence. Transferability is never guaranteed.

Can pForm keep the process confidential?+

Yes. Whole-lab and equipment sale processes typically run through a confidential listing approach — de-identified asset details and photos — with an NDA required before identifying information or facility access is shared with a prospective buyer.

What happens if no buyer wants the full lab package?+

We build a fallback into the plan from the start. If no qualified whole-lab buyer emerges within an agreed window, the plan shifts to equipment package sale, targeted resale, auction, or consignment so the exit stays on schedule.

Newsletter

Lab Asset Market Brief

Weekly biotech, pharma, and lab asset updates. One short brief.

By subscribing, you agree to receive market updates, auction notices, equipment availability emails, and asset recovery insights from pForm Asset Solutions. You can unsubscribe at any time.

Planning a Lab Closure, Sale, or Transition?

The earlier you start, the more sale-channel options and recovery value you keep on the table. Tell us about your facility and timeline, and we'll outline an exit plan.